CymaBay Therapeutics Cash from Financing (TTM) Trends

CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)

32.48 0.00 (0.00%) USD | NASDAQ | Mar 25, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	345.77M
September 30, 2023	343.04M
June 30, 2023	94.13M
March 31, 2023	93.08M
December 31, 2022	24.55M
September 30, 2022	119.71M
June 30, 2022	142.89M
March 31, 2022	143.00M
December 31, 2021	118.46M
September 30, 2021	23.38M
June 30, 2021	0.191M
March 31, 2021	0.092M
December 31, 2020	0.092M
September 30, 2020	0.289M
June 30, 2020	0.289M
March 31, 2020	0.115M
December 31, 2019	108.13M
September 30, 2019	107.87M
June 30, 2019	109.41M
March 31, 2019	104.38M
December 31, 2018	134.99M

Date	Value
September 30, 2018	135.98M
June 30, 2018	225.31M
March 31, 2018	229.74M
December 31, 2017	99.72M
September 30, 2017	97.96M
June 30, 2017	6.844M
March 31, 2017	7.619M
December 31, 2016	-0.986M
September 30, 2016	-0.244M
June 30, 2016	26.60M
March 31, 2016	26.21M
December 31, 2015	30.53M
September 30, 2015	30.33M
June 30, 2015	26.76M
March 31, 2015	27.15M
December 31, 2014	25.24M
September 30, 2014	27.97M
June 30, 2014	33.77M
March 31, 2014	33.77M
December 31, 2013	31.36M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.092M

Minimum

Dec 2020

345.77M

Maximum

Dec 2023

93.39M

Average

94.13M

Median

Jun 2023

Cash from Financing (TTM) Benchmarks